Viewing Study NCT01038635


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-25 @ 8:06 PM
Study NCT ID: NCT01038635
Status: COMPLETED
Last Update Posted: 2017-02-10
First Post: 2009-12-23
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Sponsor: M.D. Anderson Cancer Center
Organization: